Contrast Enhanced Ultrasound for Evaluation of Reflux Nephropathy
| Status: | Completed |
|---|---|
| Conditions: | Gastroesophageal Reflux Disease , Urology, Urology, Urinary Tract Infections |
| Therapuetic Areas: | Gastroenterology, Nephrology / Urology, Other |
| Healthy: | No |
| Age Range: | 8 - 50 |
| Updated: | 5/12/2018 |
| Start Date: | March 2016 |
| End Date: | November 2016 |
The study will be evaluating the efficacy and safety of a contrast drug in pediatric renal
ultrasound.
ultrasound.
Inclusion Criteria:
- Informed consent
- Age more than or equal to 8 years
- Patient with history of urinary tract infection (UTI) and history of Voiding
Cystourethrogram (VCUG) for vesicoureteral reflux
- Candidate for Dimercaptosuccinic acid (DMSA) scan or scan for renal scar
- Demonstration of renal scarring by DMSA scan or renal ultrasound without contrast
Includes healthy volunteers
Exclusion Criteria:
- Age less than 8years
- Allergy to contrast or related products
- Cardiac shunt/ congenital heart anomalies
- Abnormal baseline ECG
- Open heart surgery
- Evidence of retinopathy
- Patient in intensive care
- Unable to comply with study requirement
- History of emphysema
- Unable to maintain oxygen saturation of 92% on at room air
- Pregnancy and lactation
We found this trial at
1
site
Memphis, Tennessee 38163
Principal Investigator: David Hains, M.D.
Phone: 901-287-7485
Click here to add this to my saved trials
